HomeInsightsStock Comparison

Amrutanjan Health Care Ltd vs Astrazeneca Pharma India Ltd Stock Comparison

Amrutanjan Health Care Ltd vs Astrazeneca Pharma India Ltd Stock Comparison

Last Updated on: May 24, 2025

Key Highlights

  • The Latest Trading Price of Amrutanjan Health Care Ltd is ₹ 716.9 as of 23 May 15:30.
  • The P/E Ratio of Amrutanjan Health Care Ltd changed from 38.5 on March 2020 to 39.8 on March 2024 . This represents a CAGR of 0.67% over 5 yearsThe P/E Ratio of Astrazeneca Pharma India Ltd changed from 82.8 on March 2020 to 82.4 on March 2024 . This represents a CAGR of -0.10% over 5 years.
  • The Market Cap of Amrutanjan Health Care Ltd changed from ₹ 964.46 crore on March 2020 to ₹ 1788 crore on March 2024 . This represents a CAGR of 13.15% over 5 yearsThe Market Cap of Astrazeneca Pharma India Ltd changed from ₹ 5978 crore on March 2020 to ₹ 13301 crore on March 2024 . This represents a CAGR of 17.34% over 5 years.
  • The revenue of Amrutanjan Health Care Ltd for the Mar '25 is ₹ 140.23 crore as compare to the Dec '24 revenue of ₹ 127.11 crore. This represent the growth of 10.32% The revenue of Astrazeneca Pharma India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 448.27 crore. This represent the decline of -100%.
  • The ebitda of Amrutanjan Health Care Ltd for the Mar '25 is ₹ 22.52 crore as compare to the Dec '24 ebitda of ₹ 27.71 crore. This represent the decline of -18.73% The ebitda of Astrazeneca Pharma India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 51.42 crore. This represent the decline of -100%.
  • The net profit of Amrutanjan Health Care Ltd changed from ₹ 7.01 crore to ₹ 15.18 crore over 8 quarters. This represents a CAGR of 47.16% The net profit of Astrazeneca Pharma India Ltd changed from ₹ 53.86 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Amrutanjan Health Care Ltd changed from 25.74 % on March 2020 to 29.56 % on March 2024 . This represents a CAGR of 2.81% over 5 yearsThe Dividend Payout of Astrazeneca Pharma India Ltd changed from 3.46 % on March 2020 to 37.15 % on March 2024 . This represents a CAGR of 60.76% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Amrutanjan Health Care Ltd

  • Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu.
  • The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research.
  • Three plants have been set up in the Alandur industrial belt near Chennai to produce these products.
  • It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore.
  • Pheromones have found wide application as pesticides and are used on cotton crops.

About Astrazeneca Pharma India Ltd

  • AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
  • The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
  • The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
  • Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

Amrutanjan Health Care Ltd News Hub

News

Board of Amrutanjan Health Care recommends final dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting...

Read more

15 May 2025 17:02

News

Amrutanjan Health Care to announce Quarterly Result

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 15 ...

Read more

09 May 2025 10:58

News

Board of Amrutanjan Health Care recommends Second Interim dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting...

Read more

12 Feb 2025 17:30

News

Amrutanjan Health Care schedules board meeting

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

01 Feb 2025 10:38

News

Board of Amrutanjan Health Care recommends first interim dividend

Amrutanjan Health Care announced that the Board of Directors of the Company at its meeting...

Read more

13 Nov 2024 09:51

News

Amrutanjan Health Care to convene board meeting

Amrutanjan Health Care will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

05 Nov 2024 11:59

Astrazeneca Pharma India Ltd News Hub

News

Astrazeneca Pharma India announces board meeting date

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 3...

Read more

22 May 2025 16:02

News

AstraZeneca Pharma gets CDSCO nod to import and distribute TAGRISSO (Osimertinib)

The newly approved indication allows Osimertinib to be used in combination with pemetrexed...

Read more

05 Apr 2025 14:43

News

Astrazeneca Pharma gains after receiving approval from CDSO to import Durvalumab solution.

Through this approval, Durvalumab in combination with Tremelimumab is indicated for the tr...

Read more

03 Mar 2025 14:43

News

Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr

Revenue from operations jumped 44% to Rs 440.29 crore in Q3 FY25 as compared with Rs 305.7...

Read more

12 Feb 2025 11:47

News

Astrazeneca Pharma India to hold board meeting

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 1...

Read more

21 Jan 2025 10:45

News

Volumes spurt at Astrazeneca Pharma India Ltd counter

Happiest Minds Technologies Ltd, Campus Activewear Ltd, Cera Sanitaryware Ltd, ITI Ltd are...

Read more

30 Dec 2024 14:30

SWOT Analysis Of Amrutanjan Health Care Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Amrutanjan Health Care Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Astrazeneca Pharma India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Amrutanjan Health Care Ltd and Astrazeneca Pharma India Ltd

Which company has a larger market capitalization, Amrutanjan Health Care Ltd or Astrazeneca Pharma India Ltd?

Market cap of Amrutanjan Health Care Ltd is 2,072 Cr while Market cap of Astrazeneca Pharma India Ltd is 19,930 Cr

What are the key factors driving the stock performance of Amrutanjan Health Care Ltd and Astrazeneca Pharma India Ltd?

The stock performance of Amrutanjan Health Care Ltd and Astrazeneca Pharma India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amrutanjan Health Care Ltd and Astrazeneca Pharma India Ltd?

As of May 24, 2025, the Amrutanjan Health Care Ltd stock price is INR ₹716.9. On the other hand, Astrazeneca Pharma India Ltd stock price is INR ₹7972.0.

How do dividend payouts of Amrutanjan Health Care Ltd and Astrazeneca Pharma India Ltd compare?

To compare the dividend payouts of Amrutanjan Health Care Ltd and Astrazeneca Pharma India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions